Secondary Logo

Institutional members access full text with Ovid®

Analgesic Use and Ovarian Cancer Risk

An Analysis in the Ovarian Cancer Cohort Consortium

Trabert, Britton; Poole, Elizabeth M.; White, Emily; Visvanathan, Kala; Adami, Hans-Olov; Anderson, Garnet L.; Brasky, Theodore M.; Brinton, Louise A.; Fortner, Renee T.; Gaudet, Mia; Hartge, Patricia; Hoffman-Bolton, Judith; Jones, Michael; Lacey, James V. Jr; Larsson, Susanna C.; Mackenzie, Gerardo G.; Schouten, Leo J.; Sandler, Dale P.; O'Brien, Katie; Patel, Alpa V.; Peters, Ulrike; Prizment, Anna; Robien, Kim; Setiawan, Wendy V.; Swerdlow, Anthony; van den Brandt, Piet A.; Weiderpass, Elisabete; Wilkens, Lynne R.; Wolk, Alicja; Wentzensen, Nicolas; Tworoger, Shelley S. on behalf of the Ovarian Cancer Cohort Consortium (OC3)

Obstetrical & Gynecological Survey: October 2018 - Volume 73 - Issue 10 - p 576–578
doi: 10.1097/OGX.0000000000000601

(Abstracted from J Natl Cancer Inst 2018; doi: 10.1093/jnci/djy100)

The most fatal gynecologic cancer is ovarian cancer. This is largely due to its delayed symptom presentation and lack of early detection strategies.

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD (B.T., L.A.B., P.H., N.W.); Brigham and Women's Hospital and Harvard Medical School, Boston, MA (E.M.P.); Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle, WA (E. White, G.L.A., U.P.); Johns Hopkins Bloomberg School of Public Health, Baltimore, MD (K.V., J.H.-B.); Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (E. White, H.-O.A.); Clinical Effectiveness Research Group, Institute of Health and Society, University of Oslo, Oslo, Norway (H.-O.A.); Division of Cancer Prevention and Control, College of Medicine, The Ohio State University, Columbus, OH (T.M.B.); Division of Cancer Epidemiology, German Cancer Research Center, Heidelberg, Germany (R.T.F.); Epidemiology Research Program, American Cancer Society, Atlanta, GA (M.G., A.V.P.); Division of Genetics and Epidemiology and Division of Breast Cancer Research, The Institute of Cancer Research, London, United Kingdom (M.J., A.S.); City of Hope, Duarte, CA (J.V.L.); Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden (S.C.L., A.W.); Department of Nutrition, University of California Davis, Davis, CA (G.G.M.); Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands (L.J.S., P.A.v.d.B.); National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, NC (D.P.S., K.O.); Division of Epidemiology and Community Health, School of Public Health, and Masonic Cancer Center, University of Minnesota, Minneapolis, MN (A.P.); Department of Exercise and Nutrition Sciences, Milken Institute School of Public Health, George Washington University, Washington, DC (K.R.); University of Southern California, Los Angeles, CA (W.V.S.); Department of Community Medicine, Faculty of Health Sciences, University of Tromsø, The Arctic University of Norway, Tromsø (E. Weiderpass); Department of Research, Cancer Registry of Norway, Institute of Population Based Cancer Research, Oslo (E. Weiderpass), Norway; Genetic Epidemiology Group, Folkhälsan Research Center, Helsinki, Finland (E. Weiderpass); University of Hawaii Cancer Center, Honolulu, HI (L.R.W.); Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA (S.S.T.); and Department of Cancer Epidemiology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL (S.S.T.)

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.